Literature DB >> 14571980

Monoclonal antibody purification by affinity chromatography with ligands derived from the screening of peptide combinatory libraries.

S A Camperi1, N B Iannucci, G J Albanesi, M Oggero Eberhardt, M Etcheverrigaray, A Messeguer, F Albericio, O Cascone.   

Abstract

The peptide, Ala-Pro-Ala-Arg (APAR), was selected from the screening of a tetrapeptide combinatorial synthetic library as the ligand for affinity purification of an anti-Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) monoclonal antibody (Mab) developed in mouse ascitis. The affinity chromatographic matrix obtained by attachment of APAR to agarose, having a peptide density of 0.5 micromol ml(-1), showed a maximum capacity of 9.1 mg Mab ml(-1) and a dynamic capacity of 3.9 mg Mab ml(-1). A 95% yield of electrophoretically pure anti-GM-CSF was obtained in a single step.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14571980     DOI: 10.1023/a:1025464918453

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  4 in total

1.  Antibody purification via affinity membrane chromatography method utilizing nucleotide binding site targeting with a small molecule.

Authors:  Nur Mustafaoglu; Tanyel Kiziltepe; Basar Bilgicer
Journal:  Analyst       Date:  2016-11-28       Impact factor: 4.616

Review 2.  Fc-Binding Ligands of Immunoglobulin G: An Overview of High Affinity Proteins and Peptides.

Authors:  Weonu Choe; Trishaladevi A Durgannavar; Sang J Chung
Journal:  Materials (Basel)       Date:  2016-12-08       Impact factor: 3.623

3.  Multiplexed Competitive Screening of One-Bead-One-Component Combinatorial Libraries Using a ClonePix 2 Colony Sorter.

Authors:  R Ashton Lavoie; Alice di Fazio; Ruben G Carbonell; Stefano Menegatti
Journal:  Int J Mol Sci       Date:  2019-10-16       Impact factor: 5.923

Review 4.  Peptide Affinity Chromatography Applied to Therapeutic Antibodies Purification.

Authors:  Gabriela R Barredo-Vacchelli; Silvana L Giudicessi; María C Martínez-Ceron; Osvaldo Cascone; Silvia A Camperi
Journal:  Int J Pept Res Ther       Date:  2021-10-19       Impact factor: 1.931

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.